Insurance Coverage for Ensure and Similar Nutritional Supplements Now Requires Prescription Rationale in “Remarks” Column – Nikkei Medical

News Highlights

For nutritional supplements such as Ensure, it is now mandatory to state the reason for prescription in the “Remarks” column when seeking insurance coverage. This measure is expected to promote appropriate use and curb improper claims for medical fees. Medical institutions may face an increased administrative burden when issuing prescriptions.

M&A Medical Editorial Department’s Perspective

The new requirement to state the prescription rationale for Ensure and similar products goes beyond mere administrative complexity; it signals a subtle impact on the revenue structure of medical institutions. Particularly for facilities where prescribing nutritional supplements formed a part of their revenue, this move towards appropriate usage could directly lead to a reduction in revenue opportunities. From an M&A standpoint, accurately grasping such trends in medical fee revisions and comprehensively evaluating the profitability of target institutions becomes even more crucial. For instance, institutions with a high sales ratio or dependency on nutritional supplements should be assessed as having future revenue fluctuation risks. When considering business succession, the necessity for due diligence extends beyond just patient numbers and facilities to include the impact of these changes in medical fee systems.

Key Discussion Points from This News

• Increased administrative burden and promotion of appropriate use due to the mandatory prescription rationale for nutritional supplements.
• Impact on the revenue structure of medical institutions and business succession risks when dependency is high.
• The importance of M&A due diligence is heightened by changes in the medical fee system.
• Promoting appropriate use can serve as an opportunity for medical institutions to improve management efficiency and quality.

Practical Questions Arising from This News

• What specific administrative tasks will increase with this change?
• What kind of reasons for prescribing nutritional supplements will be accepted?
• Could this change potentially extend to other pharmaceuticals or medical procedures?

If You Feel “Should I Consult?”

If your clinic frequently prescribes nutritional supplements like Ensure, this is a good opportunity to pause and consider not only the increased administrative burden but also potential impacts on revenue amidst the trend towards appropriate usage. Especially if you are considering business succession, evaluating revenue with this in mind and establishing a post-succession system will be indispensable. M&A Medical offers business valuation services that include the impact of such regulatory changes, as well as proposals for smooth succession schemes.

M&A Medical (CentralMedience Inc.) is an M&A support institution certified by the Small and Medium Enterprise Agency, providing comprehensive support for the business succession of medical corporations, hospitals, and clinics on a success-fee-only basis. We handle consultations with strict confidentiality. Free consultations available here